Autoantibodies as Predictive and Diagnostic Markers of Idiopathic Inflammatory Myopathies

References

• Miller, F.W. (2003) "Inflammatory myopathies: polymyositis, dermatomyositis, and related conditions", In: Koopman, W.J., Boulware, D.W. and Huedebert, G.R., eds, Clinical Primer of Rheumatology (Lippincott Williams and Wilkins, Philadelphia), pp 182–198.
   Google Scholar
• Bohan, A. and Peter, LB. (1975) "Polymyositis and dermato-myositis (first of two parts)", N. Engl. J. Med. 292, 344–347. pj Callen, J.P. (2000) "Dermatomyositis", Lancet 355, 53–57.
   Google Scholar
• Mastaglia, FL. and Phillips, B.A. (2002) "Idiopathic inflammatory myopathies: epidemiology, classification, and diagnostic criteria", Rheum. Dis. Clin. N. Am. 28, 723–741.
   PubMed Web of Science ®Google Scholar
• Plotz, PH., Dalakas, M., Leff, R.L., Love, L.A., Miller, F.W. and Cronin, M.E. (1989) "Current concepts in the idiopathic inflammatory myopathies: polymyositis, dermatomyositis, and related disorders", Ann. Intern. Med. 111, 143–157.
   PubMed Web of Science ®Google Scholar
• Tynuns, K.E. and Webb, J. (1985) "Dermatopolymyositis and other connective tissue diseases: a review of 105 cases", J. Rheumatol. 12, 1140–1148.
   PubMedGoogle Scholar
• Sharp, G.C., Irvin, W.S., Tan, E.M., Gould, R.G. and Holman, H.R. (1972) "Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)", Am. J. Med. 52, 148–159.
   PubMed Web of Science ®Google Scholar
• Mimori, T. (1987) "Scleroderma-polymyositis overlap syndrome. Clinical and serologic aspects", Int. J. Dennatol. 26, 419–425.
   Google Scholar
• Targoff, IN. (2000) "Update on myositis-specific and myosins-associated autoantibodies", Curr. Opin. Rheumatol. 12, 475–481.
   PubMed Web of Science ®Google Scholar
• Levine, S.M., Rosen, A. and Casciola-Rosen, L.A. (2003) "Anti-aminoacyl tRNA synthetase immune responses: insights into the pathogenesis of the idiopathic inflammatory myopathies", Curr. Opin. Rheumatol. 15, 708–713.
   PubMed Web of Science ®Google Scholar
• Mantegazza, R., Andreetta, F., Bernasconi, P., Baggi, F., Oksenberg, J.R., Simoncini, 0., Mora, M., Cornell°, F. and Steinman, L. (1993) "Analysis of T cell receptor repertoire of muscle-infiltrating T lymphocytes in polymyositis. Restricted V alpha/beta rearrange-ments may indicate antigen-driven selection", J. Clin. Investig. 91, 2880–2886.
   Google Scholar
• O'Hanlon, T.P., Dalakas, MC., Plotz, P.H. and Miller, F.W. (1994) "Predominant TCR-alpha beta variable and joining gene expression by muscle-infiltrating lymphocytes in the idiopathic inflammatory myopathies", J. Immunol. 152, 2569–2576.
   PubMed Web of Science ®Google Scholar
• Englund, P., Nennesmo, I., Klareskog, L. and Lundberg, I.E. (2002) "Interleukin- 1 alpha expression in capillaries and major histocompatibility complex class I expression in type 11 muscle fibers from polymyositis and dermatomyositis patients: important pathogenic features independent of inflamma-tory cell clusters in muscle tissue", Arthritis Rheum. 46, 1044–1055.
   PubMedGoogle Scholar
• Nyberg, P., Wikman, AL., Nennesmo, I. and Lundberg, I. (2000) "Increased expression of interleukin lalpha and MHC class I in muscle tissue of patients with chronic, inactive polymyositis and dermatomyositis", J. Rheumatol. 27, 940–948.
   PubMedGoogle Scholar
• Askanas, V. and Engel, W.K. (2003) "Proposed pathogenetic cascade of inclusion-body myositis: importance of amyloid-beta, misfolded proteins, predisposing genes, and aging", Curr. Opin. Rheumatol. 15, 737–744.
   PubMedGoogle Scholar
• Kumamoto, T., Ueyama, H., Tsumura, H., Toyoshima, I. and Tsuda, T. (2003) "Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis", Acta. Neuropathol. (Berl).
   Google Scholar
• Arnett, F.C., Targoff, IN., Mimori, T., Goldstein, R., Warner, N.B. and Reveille, J.D. (1996) "Interrelationship of major histocompatibility complex class 11 alleles and autoantibodies in four ethnic groups with various forms of myositis", Arthritis Rheum. 39, 1507–1518.
   PubMed Web of Science ®Google Scholar
• Reed, A.M. and Ytterberg, S.R. (2002) "Genetic and environmental risk factors for idiopathic inflammatory myopathies", Rheum. Dis. Clin. N. Am. 28, 891–916.
   PubMedGoogle Scholar
• Miller, F.W., Waite, K.A., Biswas, T. and Plotz, PH. (1990) "The role of an autoantigen, histidyl-tRNA synthetase, in the induction and maintenance of autoimmunity", Proc. Natl Acad. Sci. USA 87, 9933–9937.
   PubMedGoogle Scholar
• Satoh, M., Miyazaki, K., Mimori, T., Akizuld, M., Ichikawa, Y., Homma, M., Ajmani, A.K. and Reeves, W.H. (1995) "Changing autoantibody profiles with variable clinical manifestations in a patient with relapsing systemic lupus erythematosus and poly-myositis", Br J. Rheumatol. 34, 915–919.
   PubMedGoogle Scholar
• Reichlin, M. and Arnett, Jr., F.C. (1984) "Multiplicity of antibodies in myositis sera", Arthritis Rheum. 27, 1150–1156.
   PubMed Web of Science ®Google Scholar
• Love, LA., Leff, R.L., Fraser, D.D., Targoff, I.N., Dalakas, M., Plotz, PH. and Miller, F.W. (1991) "A new approach to the classification of idiopathic inflammatory myopathy: myositis-specific autoantibodies define useful homogeneous patient groups", Medicine (Baltim.) 70, 360–374.
   PubMed Web of Science ®Google Scholar
• Leslie, D., Lipsky, P. and Notkins, A.L. (2001) "Autoantibodies as predictors of disease", J. Clin. Investig. 108, 1417–1422.
   PubMed Web of Science ®Google Scholar
• Targoff, IN., Trieu, ER, Plotz, PH. and Miller, F.W. (1992) "Antibodies to glycyl-transfer RNA synthetase in patients with myositis and interstitial lung disease", Arthritis Rheum. 35, 821–830.
   PubMed Web of Science ®Google Scholar
• Hengstman, G.J., Brouwer, R., Egberts, W.T., Seelig, H.P., Jongen, P.J., van Venrooij, W.J. and van Engelen, B.G. (2002) "Clinical and serological characteristics of 125 Dutch myositis patients. Myositis specific autoantibodies aid in the differential diagnosis of the idiopathic inflammatory myopathies", J. Neurol. 249, 69–75.
   PubMedGoogle Scholar